Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Shrinking Profits Should Not Keep You Away From This Stock

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

It came as a surprise to me when Eastman Chemical's (NYSE: EMN  ) third-quarter net income slipped at a time when chemical players are rocking the Street with outstanding results.

Just a few days ago, I wrote about how things are looking good for Eastman. But its third-quarter numbers might portray a somewhat different picture.

I became curious, and thought of digging a little deeper to know what the company has been up to. And believe me, the numbers won't look as bad once you know the full story.

What hurt the bottom line?
When volumes remained flat, what exactly drove up Eastman's revenues by 20% from the year-ago quarter to $1.8 billion? Higher prices, of course. And this wasn't surprising at all, considering how most chemical players have been witnessing a similar trend lately.

Volumes in DuPont's (NYSE: DD  ) largest segment also dipped, but higher prices resulted in its third-quarter sales growing by a good 32% from last year. The largest chemical maker, Dow Chemical (NYSE: DOW  ) , saw third-quarter volumes flat, too. But broad-based higher prices pushed its revenues by 17% from the year-ago quarter to $15.1 billion. Higher selling prices were also the primary reason behind Huntsman's (NYSE: HUN  ) 24% growth in its third-quarter revenues.

Sadly, costs -- primarily relating to outages, restructuring, and acquisitions -- were too high to boost Eastman's bottom line. Its net income thus slipped 2.9% to $165 million.

Charging ahead!
Eastman is furiously gobbling up companies to satisfy its hunger for growth. It acquired three companies in the last quarter.

One was petrochemical producer Sterling Chemicals, acquired in August. Eastman will use these acquired assets to restart its idle plasticizer manufacturing facility and add to existing capacity.

Eastman's strong focus on its plasticizer business is also evident from its capacity expansions at its other plasticizer sites. Its recent acquisition of Scandiflex, a Brazil-based plasticizer company, strengthens the argument further. This also highlights how keen Eastman is to gain traction in fast-growing emerging markets. Around 53% of Eastman's third-quarter earnings were from Asia, Europe, and Latin America combined.

These markets have caught the eye of peers as well. Huntsman, for instance, acquired an India-based chemical company, Laffans Petrochemicals, this year, and is planning major expansions in the country. Celanese (NYSE: CE  ) also derives a lot of revenue from markets like Asia and has been expanding its capacity there to meet the rising demand. This seems to be a sure-shot way to boost revenues, given how some of the biggest companies have been making the most of these growing regions.

Apart from the above additions to its largest performance chemicals segment, Eastman has made some other value business additions as well. It acquired Dynaloy, an Indiana-based specialty chemical business, to strengthen its electronics materials product line. And more recently, Eastman has added a renewable chemicals developer, TetraVitae Bioscience, that will help it deliver more effective and sustainable solutions to its customers.

The Foolish bottom line
Eastman's aggressive investment in expansions is indeed praise-worthy. A lot of capacity additions will keep it rolling. What's important to remember is that its revenue growth is strong. The company has also raised its quarterly dividend by 11% (current yield is 2.7%). I strongly feel this stock's worth a watch.

To stay updated on Eastman as it expands and acquires, make sure you add it to our watchlist service, My Watchlist. It's free, and it helps you constantly stay updated on news and analysis on your favorite companies.

Neha Chamaria does not own shares of any of the companies mentioned in this article. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (14)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1584216, ~/Articles/ArticleHandler.aspx, 10/23/2016 10:07:16 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:02 PM
EMN $66.87 Down -0.02 -0.03%
Eastman Chemical CAPS Rating: ****
CE $70.65 Down -0.25 -0.35%
Celanese CAPS Rating: *****
DD $69.70 Up +0.24 +0.35%
DuPont CAPS Rating: ****
DOW $54.10 Up +0.28 +0.52%
The Dow Chemical C… CAPS Rating: *****
HUN $16.50 Up +0.02 +0.12%
Huntsman CAPS Rating: **